Treatment Options for Sleep Apnea

Primary Treatment Approach

The American Academy of Sleep Medicine recommends Continuous Positive Airway Pressure (CPAP) as the gold standard first-line treatment for moderate to severe obstructive sleep apnea, and should be used for the entirety of the sleep period, as it demonstrates superior efficacy in reducing apnea-hypopnea index (AHI), arousal index, and oxygen desaturation while improving oxygen saturation compared to all other interventions 1, 2
The American College of Physicians suggests continuing CPAP even if used less than 4 hours per night, as studies show benefits with mean use of 3.4-3.8 hours per night including improvements in quality of life and daytime sleepiness 1
The American Academy of Sleep Medicine recommends providing supportive, educational, and behavioral interventions early in treatment to improve adherence 1

The American Academy of Sleep Medicine recommends Mandibular Advancement Devices (MADs) as first-line alternatives for patients with mild to moderate OSA who refuse or cannot tolerate CPAP, or as alternatives for those who prefer them or experience CPAP adverse effects, as they reduce AHI, arousal index, daytime sleepiness, and improve quality of life measures 1, 3, 2
The American Academy of Sleep Medicine suggests that candidates for MADs require adequate healthy teeth, no significant temporomandibular joint disorder, adequate jaw range of motion, and sufficient manual dexterity to insert/remove the device 4

The American Academy of Sleep Medicine recommends modafinil 200 mg once daily in the morning for residual excessive daytime sleepiness in OSA patients with sleepiness despite effective PAP treatment, as it is FDA-approved and provides significant benefits 6
The American Academy of Sleep Medicine suggests that topical nasal corticosteroids may improve AHI in patients with OSA and concurrent rhinitis, serving as useful adjunct to primary therapies 6

The American Academy of Pediatrics recommends screening for snoring at routine health maintenance visits; if present, perform detailed evaluation, and adenotonsillectomy is first-line treatment for pediatric patients with OSA 5
The American Academy of Sleep Medicine suggests that high-risk patients (age <3 years, cardiac complications, severe OSA, failure to thrive, obesity, craniofacial anomalies) should be hospitalized overnight after surgery with continuous pulse oximetry monitoring 5

The American Academy of Sleep Medicine recommends that all patients with OSA require ongoing, long-term management for this chronic disorder, and regular follow-up to monitor adherence to therapy, side effects, development of medical complications related to OSA, and continued resolution of symptoms 6